Key Takeaways
- Pathogenic, an indie roguelite shooter, offers a unique twist by allowing players to take on the role of pathogens.
- The game has garnered widespread praise and quickly amassed 100,000 sales since its release.
- Developer Aberrant Labs has created a fun and engaging experience that stands out in the crowded action roguelite genre.
Pathogenic, an innovative indie roguelite shooter developed by Aberrant Labs, offers players a unique perspective: they can now take on the role of pathogens waging war against human immune systems.
Unlike traditional action games where players typically fight off invaders, Pathogenic flips this dynamic, allowing gamers to experience the thrill of being a virus or bacteria.
This fresh approach has resonated with many players, leading to widespread acclaim and rapid success. Within just a couple of weeks since its release, the game has sold over 100,000 copies on Steam.
The positive reception is evident in the overwhelmingly positive review scores Pathogenic has received from gamers and critics alike, reflecting the game's ability to stand out in an already crowded market.
Developer Aberrant Labs has managed to create a compelling experience that not only challenges players but also provides a unique and entertaining twist on classic roguelite gameplay.
The game’s success can be attributed to its engaging mechanics and the innovative concept, which sets it apart from other action roguelites available today.
Players who have tried Pathogenic report feeling a sense of satisfaction in outsmarting their virtual immune systems, making the game more enjoyable than conventional cold remedies like cough syrup.
